Related Experiment Video
Updated: Aug 20, 2026
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman
Gaëlle Fromont1, Laurent Chene, Michel Vidaud
1Centre d' Etude et de Recherche en Pathologie Prostatique 3104, Université Paris VII, Paris, France. gaelle.fromont@imm.fr
Abstract:
Progression of prostate cancer to androgen independence remains the primary obstacle to improved survival. The development of more effective treatments depends on our understanding of the molecular events associated with the hormone-refractory stage. We quantified, among 90 screened genes, the expression of 37 target genes, using real-time quantitative RT-PCR. Gene expression was studied in 13 samples of HPRC compared to 33 clinically localised cancers and normal prostate tissue. We identify 19 genes with significant differential expression in HRPC compared to localised prostate cancer. Genes with decreased expression included receptors for growth factors, MMR genes and the serine protease hepsin. Analysis of increased gene expression confirmed the importance of AR upregulation and highlighted genes not previously linked to HRPC, including enzymes involved in steroid synthesis and the antiapoptotic factor survivin. Progression of prostate cancer to the hormone-refractory state is associated with differential gene expression, which may prove useful for both understanding disease progression and the development of new therapeutic approaches.
Insights
Understanding hormone-refractory prostate cancer (HRPC) progression is key to survival. This study identifies 19 differentially expressed genes in HRPC, offering insights for new treatments.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Prostate cancer progression to androgen independence (hormone-refractory prostate cancer, HRPC) limits patient survival.
- Understanding the molecular mechanisms of HRPC is crucial for developing effective therapies.
Purpose of the Study:
- To identify genes with differential expression in hormone-refractory prostate cancer (HRPC) compared to localized prostate cancer.
- To uncover molecular markers associated with prostate cancer progression to hormone independence.
Main Methods:
- Quantitative real-time RT-PCR was used to quantify the expression of 37 target genes.
- Gene expression analysis was performed on 13 HRPC samples, 33 localized prostate cancer samples, and normal prostate tissue.
Main Results:
- Nineteen genes showed significant differential expression between HRPC and localized prostate cancer.
- Decreased expression was observed for growth factor receptors, mismatch repair (MMR) genes, and hepsin.
- Increased expression included the androgen receptor (AR), steroid synthesis enzymes, and survivin.
Conclusions:
- Prostate cancer progression to the hormone-refractory state is characterized by significant changes in gene expression.
- These differentially expressed genes may serve as biomarkers for disease progression and targets for novel therapeutic strategies.
